Abundance Wealth Counselors Sells 5,371 Shares of The Procter & Gamble Company (NYSE:PG)

Abundance Wealth Counselors decreased its holdings in The Procter & Gamble Company (NYSE:PG) by 88.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 697 shares of the company’s stock after selling 5,371 shares during the period. Abundance Wealth Counselors’ holdings in The Procter & Gamble were worth $76,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. OLD Mission Capital LLC bought a new position in shares of The Procter & Gamble during the 3rd quarter worth approximately $349,000. Clarius Group LLC increased its position in shares of The Procter & Gamble by 15.2% during the fourth quarter. Clarius Group LLC now owns 23,882 shares of the company’s stock worth $3,323,000 after purchasing an additional 3,152 shares in the last quarter. Centennial Wealth Advisory LLC purchased a new stake in shares of The Procter & Gamble during the 4th quarter valued at $539,000. Insight Folios Inc boosted its position in shares of The Procter & Gamble by 5.4% in the 4th quarter. Insight Folios Inc now owns 28,629 shares of the company’s stock worth $3,983,000 after purchasing an additional 1,463 shares in the last quarter. Finally, Grant GrossMendelsohn LLC purchased a new position in The Procter & Gamble during the 4th quarter worth $1,618,000. Institutional investors own 63.05% of the company’s stock.

Shares of PG stock opened at $138.01 on Friday. The Procter & Gamble Company has a twelve month low of $111.43 and a twelve month high of $146.92. The stock has a market cap of $337.88 billion, a P/E ratio of 26.39, a P/E/G ratio of 3.25 and a beta of 0.38. The stock has a 50 day moving average of $135.28 and a 200 day moving average of $134.39. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.50.

The Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Monday, April 19th. The company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.07. The Procter & Gamble had a net margin of 18.92% and a return on equity of 30.69%. The business had revenue of $18.10 billion for the quarter, compared to analysts’ expectations of $18 billion. During the same quarter last year, the company earned $1.17 EPS. The business’s revenue was up 5.1% on a year-over-year basis. On average, research analysts predict that The Procter & Gamble Company will post 5.59 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 17th. Stockholders of record on Friday, April 23rd will be given a dividend of $0.8698 per share. The ex-dividend date of this dividend is Thursday, April 22nd. This is a boost from The Procter & Gamble’s previous quarterly dividend of $0.79. This represents a $3.48 dividend on an annualized basis and a dividend yield of 2.52%. The Procter & Gamble’s dividend payout ratio (DPR) is 67.97%.

In other The Procter & Gamble news, VP Valarie L. Sheppard sold 1,811 shares of the company’s stock in a transaction on Friday, February 26th. The shares were sold at an average price of $125.77, for a total transaction of $227,769.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nelson Peltz sold 107,372 shares of The Procter & Gamble stock in a transaction dated Tuesday, February 16th. The shares were sold at an average price of $128.00, for a total transaction of $13,743,616.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,282,873 shares of company stock valued at $306,539,932. 0.70% of the stock is owned by company insiders.

PG has been the topic of a number of research analyst reports. Zacks Investment Research lowered The Procter & Gamble from a “buy” rating to a “hold” rating and set a $139.00 price target on the stock. in a research note on Thursday, January 21st. Deutsche Bank Aktiengesellschaft decreased their price target on shares of The Procter & Gamble from $159.00 to $158.00 and set a “buy” rating for the company in a report on Tuesday, April 27th. Sanford C. Bernstein initiated coverage on shares of The Procter & Gamble in a report on Tuesday, January 19th. They set a “market perform” rating and a $149.00 price objective on the stock. JPMorgan Chase & Co. reduced their target price on The Procter & Gamble from $153.00 to $148.00 and set an “overweight” rating for the company in a research note on Thursday, April 22nd. Finally, Independent Research upgraded The Procter & Gamble from a “hold” rating to a “buy” rating and set a $149.00 price target on the stock in a research note on Friday, January 22nd. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The Procter & Gamble presently has an average rating of “Buy” and an average price target of $148.93.

The Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care.

Read More: Stock Market – What is a circuit breaker?

Institutional Ownership by Quarter for The Procter & Gamble (NYSE:PG)

Receive News & Ratings for The Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.